PAREXEL International Corporation , a leading global biopharmaceutical services provider, today announced that Bristol-Myers Squibb, a global biopharmaceutical company, has established a strategic partnership with PAREXEL to enable greater effectiveness in clinical development.
Bristol-Myers Squibb establishes strategic partnership with PAREXEL to enable greater effectiveness